Cell and Gene Therapy Innovations in the China Biopharmaceuticals Market
Rapidly advancing autologous CAR-T cell therapies, viral vector gene delivery platforms, and mRNA therapeutics are establishing leadership in the China Biopharmaceuticals Market. Chinese clinical research institutions lead global volume rankings for active CAR-T clinical trials targeting hematological malignancies and refractory solid tumors. Regulatory pathways established by the National...
0 Comments 0 Shares 163 Views 0 Reviews